Top compounds associated with response to BOLA2


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-07
mRNA Axitinib CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA tivozanib CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA barasertib CTRPv2 pan-cancer AAC -0.12 0.0001
Download CSV